YOSHIKI Auctions Beloved Crystal Piano to Support Victims of Japan Earthquake, Raising 40 Million Yen
International Superstar Said at the Historical TCL Chinese Theatre Hand and Footprint Unveiling Ceremony: “I want to expand the circle of support.” LOS ANGELES, Jan. 16, 2024 /PRNewswire/ — International superstar YOSHIKI auctioned his beloved crystal piano this week, with the winn
Deka Lash Again Ranked #1 in its Category in Franchise 500
Ranked #1 in Lash, Brow and Skincare Category PITTSBURGH, Jan. 16, 2024 /PRNewswire/ — Deka Lash, the pioneering beauty brand specializing in eyelash extensions and brow services, has been once again named to Entrepreneur magazine’s Franchise 500®, ranked #1 in the Lash Extension, Br
EnLink Midstream Expands Common Unit Repurchase Authorization, Increases Quarterly Distribution, and Updates Financial Policy
The company also schedules webcast and call to discuss quarterly and year-end earnings and 2024 guidance DALLAS, Jan. 16, 2024 /PRNewswire/ — EnLink Midstream, LLC (NYSE: ENLC) (EnLink) announced today that the EnLink Board of Directors (Board) completed its expanded 2023 common unit repurchas
HILCO REAL ESTATE ANNOUNCES A PORTFOLIO OF FIVE SERVICE STATIONS IN CENTRAL IOWA AVAILABLE FOR SALE
NORTHBROOK, Ill., Jan. 16, 2024 /PRNewswire/ — Hilco Real Estate, LLC, announces February 21, 2024 as the bid deadline for the sale of a prime portfolio of service stations. Consisting of five Circle K gas stations, all featuring Phillips 66 gasoline, these strategically located properties pre
Sjogren’s Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players – Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
The Sjogren’s syndrome market is expected to be mainly driven by the increasing prevalence of the disease, along with the promising emerging pipeline therapies with a new mechanism of action, will fuel the Sjogren’s syndrome market. LAS VEGAS, Jan. 16, 2024 /PRNewswire/ — DelveInsi
SecureCRT 9.5 (Official) and SecureFX 9.5 (Official) from VanDyke Software Save System Administrators Time with Enhanced Credentials Management
ALBUQUERQUE, N.M., Jan. 16, 2024 /PRNewswire/ — VanDyke Software®, a developer of multi-platform secure terminal emulation and secure file transfer software, today announced new official releases of SecureCRT® 9.5 and SecureFX® 9.5. SecureCRT Enhanced Credentials Management Saves Time When
Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
30% ORR and 93% DCR across heterogenous second-line CRC patientstreated with DKN-01 plus bevacizumab and chemotherapy Subgroup analysis reveals greatest benefit in left-sided tumors, particularly rectal and rectosigmoid patients with 46% ORR, 100% DCR, and preliminary median PFS of 9.4 months. Leap
One Million Truths Assembles Scientists, U.S. Technology Giants, and U.S. Organizations for Unprecedented Research and AI-Driven Solutions to Racial Conflict
Phase II of the Project Launches on National Day of Racial Healing, January 16, 2024 LOS ANGELES, Jan. 16, 2024 /PRNewswire/ — One Million Truths (OMT), a science-based nonprofit dedicated to building solutions to resolve racial conflict by leveraging artificial intelligence (AI), today announ
DexKo Global Inc. Acquires Cerka Industries Ltd.
NOVI, Mich., Jan. 16, 2024 /PRNewswire/ — DexKo Global Inc., a global leader in highly engineered trailer running gear, chassis assemblies and related components, announced today that is has completed the acquisition of Cerka Industries Ltd. (“Cerka”) located in Milton, Ontario.
Respiratory Devices Growth Opportunity Analysis 2024: Growth Prospects with Advanced Connectivity and Remote Monitoring
DUBLIN, Jan. 16, 2024 /PRNewswire/ — The “Growth Opportunities in Respiratory Devices” report has been added to ResearchAndMarkets.com’s offering. This study analyzes the respiratory devices market, including market estimates, forecasts, growth rates, trends, challenges, a
